Literature DB >> 10433694

Crystal structure of human quinone reductase type 2, a metalloflavoprotein.

C E Foster1, M A Bianchet, P Talalay, Q Zhao, L M Amzel.   

Abstract

In mammals, two separate but homologous cytosolic quinone reductases have been identified: NAD(P)H:quinone oxidoreductase type 1 (QR1) (EC 1.6.99.2) and quinone reductase type 2 (QR2). Although QR1 and QR2 are nearly 50% identical in protein sequence, they display markedly different catalytic properties and substrate specificities. We report here two crystal structures of QR2: in its native form and bound to menadione (vitamin K(3)), a physiological substrate. Phases were obtained by molecular replacement, using our previously determined rat QR1 structure as the search model. QR2 shares the overall fold of the major catalytic domain of QR1, but lacks the smaller C-terminal domain. The FAD binding sites of QR1 and QR2 are very similar, but their hydride donor binding sites are considerably different. Unexpectedly, we found that QR2 contains a specific metal binding site, which is not present in QR1. Two histidine nitrogens, one cysteine thiol, and a main chain carbonyl group are involved in metal coordination. The metal binding site is solvent-accessible, and is separated from the FAD cofactor by a distance of about 13 A.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433694     DOI: 10.1021/bi990799v

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  Identification of an ancillary protein, YabF, required for activity of the KefC glutathione-gated potassium efflux system in Escherichia coli.

Authors:  S Miller; L S Ness; C M Wood; B C Fox; I R Booth
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

2.  Crystal structures of the tryptophan repressor binding protein WrbA and complexes with flavin mononucleotide.

Authors:  Jason Gorman; Lawrence Shapiro
Journal:  Protein Sci       Date:  2005-12       Impact factor: 6.725

3.  A tandem orthogonal proteolysis strategy for high-content chemical proteomics.

Authors:  Anna E Speers; Benjamin F Cravatt
Journal:  J Am Chem Soc       Date:  2005-07-20       Impact factor: 15.419

4.  Crystallization and preliminary X-ray characterization of the Bacillus amyloliquefaciens YwrO enzyme.

Authors:  Majed M AbuKhader; John Heap; Cristina I De Matteis; Stephen W Doughty; Nigel Minton; Max Paoli
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2007-08-10

5.  Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities.

Authors:  Arup Maiti; P V Narasimha Reddy; Megan Sturdy; Laura Marler; Scott D Pegan; Andrew D Mesecar; John M Pezzuto; Mark Cushman
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

6.  Structures of the PutA peripheral membrane flavoenzyme reveal a dynamic substrate-channeling tunnel and the quinone-binding site.

Authors:  Harkewal Singh; Benjamin W Arentson; Donald F Becker; John J Tanner
Journal:  Proc Natl Acad Sci U S A       Date:  2014-02-18       Impact factor: 11.205

7.  Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones.

Authors:  Nilesh W Gaikwad; Li Yang; Eleanor G Rogan; Ercole L Cavalieri
Journal:  Free Radic Biol Med       Date:  2008-11-01       Impact factor: 7.376

8.  Crystal structure of quinone reductase 2 in complex with resveratrol.

Authors:  Leonid Buryanovskyy; Yue Fu; Molly Boyd; Yuliang Ma; Tze-chen Hsieh; Joseph M Wu; Zhongtao Zhang
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

9.  Chloroquine binding reveals flavin redox switch function of quinone reductase 2.

Authors:  Kevin K K Leung; Brian H Shilton
Journal:  J Biol Chem       Date:  2013-03-07       Impact factor: 5.157

10.  KTN (RCK) domains regulate K+ channels and transporters by controlling the dimer-hinge conformation.

Authors:  Tarmo P Roosild; Samantha Castronovo; Samantha Miller; Chan Li; Tim Rasmussen; Wendy Bartlett; Banuri Gunasekera; Senyon Choe; Ian R Booth
Journal:  Structure       Date:  2009-06-10       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.